Reuters Health Stories
British expats force Spanish healthcare rethink
MADRID (Reuters) - Britons living in the southeastern Spanish region of Valencia have forced the local government to drop plans to strip thousands of expatriates of the right to public healthcare, campaigners said on Friday.
7/4/2008 3:00:25 PM
Cadila sets share swap ratio for consumer unit demerger
MUMBAI (Reuters) - Cadila Healthcare Ltd's shareholders will get 4 shares in subsidiary Carnation Nutra-Analogue Foods Ltd for every 15 held, following the merger of its consumer products division into Carnation, the drug firm said.
7/4/2008 1:00:24 PM
Czech central bank says received Sanofi bid
PRAGUE (Reuters) - The Czech central bank (CNB) has received for a review a takeover proposal from Sanofi-Aventis for generic drug maker Zentiva, a CNB spokesman said on Friday.
7/4/2008 11:00:23 AM
USANA Health says board rejects CEO's amended offer
BANGALORE (Reuters) - USANA Health Sciences Inc said its board asked shareholders to reject the amended tender offer by a group led by its chief executive to take the nutritional and personal care products maker private.
7/4/2008 10:00:46 AM
Bentley says Teva to pay reduced price to adjust CPEX spin-off
BANGALORE (Reuters) - Bentley Pharmaceuticals Inc said Teva Pharmaceutical Industries Ltd will now pay a reduced price of $14.82 per share for the company after adjusting the spin-off of its drug delivery business, CPEX Pharmaceuticals Inc.
7/4/2008 10:00:23 AM
Combination drug appears useful for hand osteoarthritis
NEW YORK (Reuters Health) - The synergistic drug candidate CRx-102, which combines dipyridamole with low dose prednisolone, is a safe and effective treatment for reducing pain in patients with hand osteoarthritis, according to a report in the June 19th issue of the Annals of the Rheumatic Diseases.
7/4/2008 9:33:22 AM
Survival after radical cystectomy linked to number of lymph nodes removed
NEW YORK (Reuters Health) - More extensive lymphadenectomy is associated with improved survival in patients with lymph node-positive bladder cancer undergoing radical cystectomy, according to a report in the June 1st Cancer.
7/4/2008 9:30:22 AM
Education reduces children's need for anesthesia during radiotherapy
NEW YORK (Reuters Health) - Among young patients with cancer, a psychoeducational intervention reduces the percentage of patients requiring anesthesia during radiation treatment, Swiss researchers report in a June 4th issue of the BioMed Central journal Radiation Oncology.
7/4/2008 9:26:22 AM
Thrombus protein linked to mortality in acute coronary syndromes
NEW YORK (Reuters Health) - Elevated levels of thrombus precursor protein (TpP), a form of soluble fibrin, are associated with an increased risk of death or ischemic complications in patients with acute coronary syndrome (ACS), new research shows.
7/4/2008 9:22:53 AM
Myofilament mutations linked to poorer outcomes in hypertrophic cardiomyopathy
NEW YORK (Reuters Health) - Myofilament protein gene mutations are associated with adverse long-term outcomes in patients with hypertrophic cardiomyopathy (HCM), according to a report in the June issue of the Mayo Clinic Proceedings.
7/4/2008 9:20:22 AM
SGA children may develop visceral adiposity without being overweight
NEW YORK (Reuters Health) - Children born small for gestational age (SGA) are prone to develop visceral adiposity, sometimes without being overweight, Spanish and Belgian researchers report in the June issue of the Journal of Clinical Endocrinology and Metabolism.
7/4/2008 9:16:52 AM
High-risk HPV DNA detected in human breast milk
NEW YORK (Reuters Health) - Human papillomavirus-16 (HPV-16) DNA can be detected in human breast milk collected during the early postpartum period, researchers in Finland report in the June issue of the Pediatric Infectious Disease Journal.
7/4/2008 9:12:52 AM
Single-port laparoscopy varicocelectomy described
NEW YORK (Reuters Health) - In a new report, clinicians from the Cleveland Clinic describe the first use, to their knowledge, of single-port laparoscopy to perform varicocelectomy in children.
7/4/2008 9:08:22 AM
Heart failure outcomes worse in diabetics with preserved ejection fraction
NEW YORK (Reuters Health) - Diabetes is an independent risk factor for cardiovascular morbidity and mortality in patients with heart failure regardless of ejection fraction -- but more strongly so for those with preserved ejection fraction -- investigators in Europe and North America report.
7/4/2008 9:06:22 AM
Zeltia eyes revenue boost from cancer drug -report
MADRID (Reuters) - Spanish pharmaceutical company Zeltia expects to boost revenue after approval for its cancer drug Yondelis is extended to ovarian cancer treatment, financial daily Negocio said on Friday.
7/4/2008 9:00:53 AM
Polish watchdog clears Richter buy of Polpharma
WARSAW/BUDAPEST (Reuters) - Poland's competition authority on Friday cleared the purchase of Polpharma by Hungary's Richter Gedeon, paving the way for the creation of central Europe's top pharmaceuticals group.
7/4/2008 9:00:45 AM
Panacea Biotec to set up hospital, shares rise
MUMBAI (Reuters) - Drugmaker Panacea Biotec Ltd said on Friday it would set up a multi-specialty hospital near Delhi in collaboration with a private firm, marking its foray into healthcare services and lifting the shares.
7/4/2008 9:00:30 AM
Biliary complications more common in living donors of right liver lobe grafts
NEW YORK (Reuters Health) - Living liver donors are significantly more likely to experience biliary complications when donating a right lobe than a left lobe, results of a study from Japan suggest. The researchers also found that endoscopic management of these complications is usually effective when conservative therapy fails.
7/4/2008 9:00:22 AM
Implantable recorder may determine etiology of recurrent syncope in children
NEW YORK (Reuters Health) - In children with syncope or seizures and risk factors for life-threatening arrhythmia, an implantable loop recorder (ILR) may be more effective than noninvasive testing for the long-term monitoring that is often required to obtain a diagnosis, physicians in Scotland suggest.
7/4/2008 8:59:22 AM
Pegylated liposomal doxorubicin effective in hard-to-treat cutaneous T-cell lymphoma
NEW YORK (Reuters Health) - Pegylated liposomal doxorubicin (Caelyx; Schering-Plough) is an effective therapy for advanced or refractory cutaneous T-cell lymphoma (CTCL), results of a study confirm.
7/4/2008 8:54:22 AM
LOOKING FOR EXPERT ADVICE?
Experts here are available to answer all your questions!
|
 |
|
